Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Cardiovasc. Med.

Sec. General Cardiovascular Medicine

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1577186

This article is part of the Research TopicRecent Advances in Mitochondria-Associated Endoplasmic Reticulum Membranes (MAMs) in Heart-Related Diseases: Volume IIView all 6 articles

Endoplasmic Reticulum Stress in Cardiomyopathies: From the Unfolded Protein Response to Therapeutic Opportunities

Provisionally accepted
Yueqing  QiuYueqing Qiu1,2Zhenyi  ChenZhenyi Chen1,2*Pingge  HePingge He1Zhentao  WangZhentao Wang1,2
  • 1Henan University of Chinese Medicine, Zhengzhou, Henan Province, China
  • 2Henan Province Hospital of Traditional Chinese Medicine, Zhengzhou, Henan Province, China

The final, formatted version of the article will be published soon.

The endoplasmic reticulum (ER), a central organelle responsible for maintaining protein homeostasis, calcium balance, and lipid metabolism, is essential for cardiovascular integrity. Functional disruption—referred to as endoplasmic reticulum stress (ERS)—has been recognized as a major pathogenic driver across diverse cardiovascular disorders. Under pathological conditions such as hypoxia, nutrient deprivation, or infection, sustained ERS activates the unfolded protein response (UPR). While initially adaptive, prolonged or excessive ERS initiates apoptotic cascades, severely impairing cardiomyocyte metabolism, structure, and survival.This review examines the pivotal contribution of dysregulated ERS to the pathogenesis of various cardiomyopathy subtypes, including dilated, diabetic, hypertrophic, and arrhythmogenic right ventricular forms. We outline how ERS fosters maladaptive cardiac remodeling by promoting cardiomyocyte apoptosis and exacerbating oxidative stress, ultimately leading to heart failure. Special attention is given to the complex crosstalk between ERS-related signaling pathways (e.g., PERK, IRE1α, ATF6) and disease progression, with detailed analysis of key regulatory molecules, pathogenic genetic variants, and epigenetic alterations. Integrating recent advances, we highlight the therapeutic potential of targeting ERS pathways as a novel approach to cardiomyopathy treatment, offering a conceptual framework for future translational research and precision medicine strategies.

Keywords: Endoplasmic Reticulum Stress, Unfolded Protein Response, dilated cardiomyopathy, Diabetic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Hypertrophic Cardiomyopathy

Received: 15 Feb 2025; Accepted: 18 Aug 2025.

Copyright: © 2025 Qiu, Chen, He and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Zhenyi Chen, Henan University of Chinese Medicine, Zhengzhou, 450008, Henan Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.